SIGMAPHARM LABORATORIES Trademark

Trademark Overview

On Monday, April 13, 2009, a trademark application was filed for SIGMAPHARM LABORATORIES with the United States Patent and Trademark Office. The USPTO has given the SIGMAPHARM LABORATORIES trademark a serial number of 77978825. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, June 1, 2023. This trademark is owned by SigmaPharm Laboratories, LLC. The SIGMAPHARM LABORATORIES trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections
sigmapharm laboratories

General Information

Serial Number77978825
Word MarkSIGMAPHARM LABORATORIES
Filing DateMonday, April 13, 2009
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, June 1, 2023
Registration Number5119591
Registration DateTuesday, January 10, 2017
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, September 7, 2010

Trademark Statements

Indication of Colors claimedColor is not claimed as a feature of the mark.
NOT AVAILABLE"LABORATORIES"
Goods and ServicesPharmaceutical preparations, namely, a drug delivery system comprising solid dosage delivery agents and a wide variety of therapeutic agents in molecular or amorphous state, in the form of tablets, capsules and powder dosage forms, prepared using company's patented technology platforms which will result into more bioavailable and stable dosage forms of therapeutic agents for the treatment of hypertension, depression, thyroid deficiency syndrome, hepatitis and, HIV and fungal infections
Pseudo MarkSIGMA PHARM LABORATORIES; SIGMA PHARMACEUTICAL LABORATORIES
Description of MarkThe mark consists of two circles, one within the other. The circles do not intersect. Portions of the circles are intersected perpendicularly by a straight line. A straight line protrudes outward to the left at the top of the largest circle. The words "SigmaPharm Laboratories" are depicted directly beneath the circles. The logo depicts the Greek character "phi" inside the Greek character "sigma".

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 31, 2009
Primary Code005
First Use Anywhere DateTuesday, March 31, 2009
First Use In Commerce DateTuesday, March 31, 2009

Trademark Owner History

Party NameSigmaPharm Laboratories, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020
Party NameSigmaPharm Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020
Party NameSigmaPharm Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020

Trademark Events

Event DateEvent Description
Thursday, April 16, 2009NEW APPLICATION ENTERED
Friday, April 17, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 18, 2009NOTICE OF DESIGN SEARCH CODE MAILED
Monday, June 29, 2009ASSIGNED TO EXAMINER
Wednesday, July 1, 2009NON-FINAL ACTION WRITTEN
Wednesday, July 1, 2009NON-FINAL ACTION E-MAILED
Wednesday, July 1, 2009NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 30, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 30, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, December 31, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, January 13, 2010NON-FINAL ACTION WRITTEN
Wednesday, January 13, 2010NON-FINAL ACTION E-MAILED
Wednesday, January 13, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 13, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, July 13, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, July 13, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, July 20, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 2, 2010ASSIGNED TO LIE
Monday, August 2, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 7, 2010PUBLISHED FOR OPPOSITION
Tuesday, September 7, 2010OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, October 6, 2010OPPOSITION PAPERS RECEIVED AT TTAB
Wednesday, October 6, 2010OPPOSITION INSTITUTED NO. 999999
Monday, February 9, 2015OPPOSITION DISMISSED NO. 999999
Monday, April 27, 2015OPPOSITION TERMINATED NO. 999999
Monday, April 27, 2015TTAB RELEASE CASE TO TRADEMARKS
Tuesday, June 9, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 27, 2015SOU TEAS EXTENSION RECEIVED
Friday, November 27, 2015SOU EXTENSION 1 FILED
Friday, November 27, 2015SOU EXTENSION 1 GRANTED
Tuesday, December 1, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 5, 2016SOU TEAS EXTENSION RECEIVED
Wednesday, July 6, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Sunday, June 5, 2016SOU EXTENSION 2 FILED
Thursday, July 14, 2016SOU EXTENSION 2 GRANTED
Friday, July 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 7, 2016SOU TEAS EXTENSION RECEIVED
Monday, November 7, 2016SOU EXTENSION 3 FILED
Monday, November 14, 2016SOU EXTENSION 3 GRANTED
Tuesday, November 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 21, 2016TEAS STATEMENT OF USE RECEIVED
Monday, November 21, 2016TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, November 23, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, November 21, 2016DIVISIONAL REQUEST RECEIVED
Monday, December 5, 2016DIVISIONAL PROCESSING COMPLETE
Monday, November 21, 2016USE AMENDMENT FILED
Monday, December 5, 2016STATEMENT OF USE PROCESSING COMPLETE
Tuesday, December 6, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 7, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, December 8, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, January 10, 2017REGISTERED-PRINCIPAL REGISTER
Wednesday, January 25, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 9, 2017REVIEW OF CORRESPONDENCE COMPLETE - CERTIFICATE OF REG MAILED
Friday, February 10, 2017FAX RECEIVED
Monday, February 13, 2017REVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD
Monday, January 10, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, November 22, 2022TEAS SECTION 8 & 15 RECEIVED
Friday, March 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, March 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 1, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 1, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 1, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Saturday, January 10, 2026COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

Related Keywords

laboratories sigmapharm dosage agents therapeutic delivery forms more bioavailable stable result will